Skip to main content

Table 1 Details of the subjects

From: Correlation between anti-thyroid peroxidase antibody levels and diffuse thyroid uptake of 18F-fluorodeoxyglucose in Hashimoto’s thyroiditis: a retrospective study

Subject number Age, sex Findings in thyroid ultrasonography TSH (μIU/mL) FT4 (ng/dL) FT3 (pg/mL) L-T4 replacement dose (μg/day) Tg-Ab (IU/mL) TPO-Ab (IU/mL) SUV max Interval Between FDG-PET and thyroid test (days)
Diffuse uptake
 1 51 F Hetero, Hypo 22.43 1.06 2.20 0 143 22 3.322 13
 2 78 F Hetero 6.73 0.78 2.08 0 >  4000 487 8.125 11
 3 68 F Hetero, Hypo 73.06 0.57 2.37 25 >  4000 16 3.741 28
 4 59 F Hetero 6.43 0.93 3.21 0 n.a. 184 6.070 64
 5 80 M Rough, Hetero 28.59 1.07 2.56 0 >  4000 >  600 5.714 3
 6 86 F Hetero 21.04 0.68 1.75 12.5 476 53 3.354 1
 7 64 F Hetero 3.79 1.32 1.16 0 122 29 2.923 1
 8 66 M Hetero, Hypo 8.45 0.93 2.64 0 >  4000 >  600 6.165 21
 9 78 F Rough, Hetero 87.87 0.50 1.50 25 n.a. >  600 12.023 4
 10 41 F Rough, Homo 46.21 0.94 1.58 125 626 >  600 9.985 3
 11 43 F Hetero 3.24 1.31 2.49 0 537 332 4.113 7
 12 67 F Rough, Hetero 25.11 0.94 3.04 0 2940 184 3.340 24
 13 63 M Rough, Hetero 266.1 0.19 1.16 0 1360 72 3.868 19
Without diffuse uptake
 14 74 F Homo 0.033 1.23 3.12 0 147 10 2.492 10
 15 68 F Homo 11.01 1.09 2.45 0 465 8 2.364 39
 16 50 M Homo 5.38 0.96 2.15 0 18 22 1.535 14
 17 80 F Homo 12.27 1.56 0.89 100 18 16 1.337 1
 18 74 M Fine, Homo 11.23 1.11 2.39 0 16 18 1.704 83
  1. F female, M male, TSH serum thyroid stimulating hormone, FT4 serum free T4, FT3 serum free T3, L-T4 levothyroxine, Tg-Ab anti-thyroglobulin antibody, TPO-Ab anti-thyroid peroxidase antibody, SUVmax maximum standardized uptake, FDG 18F-fluorodeoxyglucose, PET positron emission tomography, F female, M male, Hetero heterogenous, Hypo hypoechoic, Homo homogenous, n.a. not assessed